Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,006 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders.
David M, Cross NC, Burgstaller S, Chase A, Curtis C, Dang R, Gardembas M, Goldman JM, Grand F, Hughes G, Huguet F, Lavender L, McArthur GA, Mahon FX, Massimini G, Melo J, Rousselot P, Russell-Jones RJ, Seymour JF, Smith G, Stark A, Waghorn K, Nikolova Z, Apperley JF. David M, et al. Among authors: hughes g. Blood. 2007 Jan 1;109(1):61-4. doi: 10.1182/blood-2006-05-024828. Epub 2006 Sep 7. Blood. 2007. PMID: 16960151 Free article.
Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders.
Baxter EJ, Kulkarni S, Vizmanos JL, Jaju R, Martinelli G, Testoni N, Hughes G, Salamanchuk Z, Calasanz MJ, Lahortiga I, Pocock CF, Dang R, Fidler C, Wainscoat JS, Boultwood J, Cross NC. Baxter EJ, et al. Among authors: hughes g. Br J Haematol. 2003 Jan;120(2):251-6. doi: 10.1046/j.1365-2141.2003.04051.x. Br J Haematol. 2003. PMID: 12542482 Free article.
The ELIXIR Biodiversity Community: Understanding short- and long-term changes in biodiversity.
Waterhouse RM, Adam-Blondon AF, Balech B, Barta E, Ying Shi Chua P, Di Cola V, Heil KF, Hughes GM, Jermiin LS, Kalaš M, Lanfear J, Pafilis E, Palagi PM, Papageorgiou AC, Paupério J, Psomopoulos F, Raes N, Burgin J, Gabaldón T. Waterhouse RM, et al. Among authors: hughes gm. F1000Res. 2024 May 22;12:ELIXIR-499. doi: 10.12688/f1000research.133724.2. eCollection 2023. F1000Res. 2024. PMID: 38882711 Free PMC article. Review.
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: Insights From Afatinib Clinical Trials Across Diverse Cancer Indications.
Hunter Hall R, Wright CL, Hughes GK, Peña AM, Ladd C, Gardner B, McIntire R, Ferrell M, Rubenstein J, Tuia J, Haslam A, Prasad V, Vassar M. Hunter Hall R, et al. Among authors: hughes gk. Clin Ther. 2024 Jun 1:S0149-2918(24)00087-0. doi: 10.1016/j.clinthera.2024.04.006. Online ahead of print. Clin Ther. 2024. PMID: 38825553
Mitochondrial and microbial diversity of the invasive mosquito vector species Culex tritaeniorhynchus across its extensive inter-continental geographic range.
Jeffries CL, Tantely LM, Kadriaj P, Blagrove MSC, Lytra I, Orsborne J, Al-Amin HM, Mohammed AR, Alam MS, Girod R, Afrane YA, Bino S, Robert V, Boyer S, Baylis M, Velo E, Hughes GL, Walker T. Jeffries CL, et al. Among authors: hughes gl. Wellcome Open Res. 2024 Jan 12;9:18. doi: 10.12688/wellcomeopenres.20761.1. eCollection 2024. Wellcome Open Res. 2024. PMID: 38800519 Free PMC article.
3,006 results